| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/04/2007 | WO2006114702A3 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor |
| 01/04/2007 | WO2006067614A3 Heteroaromatic derivatives useful as anticancer agents |
| 01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
| 01/04/2007 | WO2006043083A3 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 01/04/2007 | WO2006009805A3 Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors |
| 01/04/2007 | WO2005069894A8 Conformationally constrained smac mimetics and the uses thereof |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 01/04/2007 | US20070004779 Process for producing crystal |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004705 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | US20070004674 Remedy for diseases associated with immunoglobulin gene translocation |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004655 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors |
| 01/04/2007 | US20070004632 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 01/04/2007 | US20070004619 Relaxin superfamily peptide analogues |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070004008 Human ccv polypeptides |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003614 Pharmaceutical compositions comprising active vitamin D compounds |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003567 Composition and methods for enhancing immunogenecity of antigens |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003542 Methods for treating diseases or conditions with peptide constructs |
| 01/04/2007 | DE102005030293A1 Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren Use of nonsteroidal progesterone receptor modulators |
| 01/04/2007 | CA2617222A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | CA2613632A1 Benzenoid ansamycin derivative |
| 01/04/2007 | CA2612686A1 Benzopyranone compounds for treating cancer |
| 01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | CA2611972A1 Physiologically active substance nk13650p3, method of producing the same and use thereof |
| 01/04/2007 | CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 01/04/2007 | CA2611814A1 Cd19 antibodies and their uses |
| 01/04/2007 | CA2610889A1 Active fraction of a polar solvent extract from the latex of euphorbiaceae plants |
| 01/04/2007 | CA2610209A1 4-anilino-3-quinolinecarbonitriles for the treatment of cancer |
| 01/04/2007 | CA2606958A1 Synthesis of anastrozole and purification of one of its intermediate |
| 01/04/2007 | CA2606945A1 An impurity of anastrozole intermediate, and uses thereof |
| 01/03/2007 | EP1739186A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |
| 01/03/2007 | EP1739173A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738772A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same |
| 01/03/2007 | EP1738771A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF |
| 01/03/2007 | EP1738759A1 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
| 01/03/2007 | EP1737961A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 01/03/2007 | EP1737884A1 Alpha helical mimics, their uses and methods for their production |
| 01/03/2007 | EP1737882A1 Peptide inhibitors of metalloproteinase activity |
| 01/03/2007 | EP1737874A1 Compositions comprising organometallic molybdenum compounds for treating cancer |
| 01/03/2007 | EP1737858A1 Sulfonamides |
| 01/03/2007 | EP1737825A1 Geldanamycin and derivatives inhibit cancer invasion and identify novel targets |
| 01/03/2007 | EP1737496A2 Novel g-csf conjugates |
| 01/03/2007 | EP1737485A2 Mucinous glycoprotein (muc-1) vaccine |
| 01/03/2007 | EP1737472A2 Effective treatment of tumors and cancer with triciribine and related compounds |
| 01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737461A1 Carboline derivatives useful in the inhibition of angiogenesis |
| 01/03/2007 | EP1737452A1 Angiogenesis-affecting compounds and methods of use thereof |
| 01/03/2007 | EP1737451A2 Monocyclic heterocycles as kinase inhibitors |
| 01/03/2007 | EP1737444A1 C7 lactyloxy-substituted taxanes |
| 01/03/2007 | EP1641466B1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 01/03/2007 | EP1633394B1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 01/03/2007 | EP1553938B1 Use of epothilone derivatives for the treatment of hyperparathyroidism |
| 01/03/2007 | EP1539804B1 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 01/03/2007 | EP1509230B1 Gefitinib (iressa) for the treatment of cancer |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1448168B1 Pharmaceutical formulation comprising bicalutamide |
| 01/03/2007 | EP1439843A4 Tetracycline derivatives and methods of use thereof |
| 01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1389617B1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 01/03/2007 | EP1362601B1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1337551B1 Substance p analogs for the treatment of cancer |
| 01/03/2007 | EP1334124B1 Diastereomeric peptides and pharmaceutical compositions comprising them |
| 01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 01/03/2007 | EP1304371B1 Cds1 knockout mice and cell lines established thereof |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1231914B1 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 01/03/2007 | EP1221439B1 Tetrahydroquinoline derivatives |
| 01/03/2007 | EP1173765B1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0865295B1 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 01/03/2007 | CN1890252A New class of gamma delta T cells activators and use thereof |
| 01/03/2007 | CN1890249A Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 01/03/2007 | CN1890221A 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them |
| 01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
| 01/03/2007 | CN1889971A Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |